生物科技LOF(501009)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
186,396.11 |
- |
416,268.69 |
305,551.37 |
| 存出保证金 |
80,308.52 |
58,058.77 |
88,333.98 |
17,051.58 |
| 交易性金融资产 |
2,119,945,701.42 |
2,327,069,154.11 |
2,301,274,462.77 |
2,200,820,940.06 |
| 其中:股票投资 |
2,078,014,524.98 |
2,285,425,764.93 |
2,290,148,978.80 |
2,195,729,988.00 |
| 债券投资 |
41,931,176.44 |
41,643,389.18 |
11,125,483.97 |
5,090,952.06 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
15,003,704.79 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
7,406,361.37 |
2,233,179.28 |
1,828,607.98 |
2,652,657.60 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
2,209,131,965.30 |
2,438,481,332.95 |
2,429,403,512.53 |
2,344,287,867.36 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
- |
- |
- |
- |
| 应付赎回款 |
3,252,450.21 |
2,461,198.49 |
3,569,625.57 |
1,993,482.90 |
| 应付管理人报酬 |
1,440,203.41 |
1,514,028.00 |
1,606,644.65 |
1,502,257.61 |
| 应付托管费 |
192,027.13 |
201,870.42 |
214,219.26 |
200,301.03 |
| 应付销售服务费 |
237,465.75 |
259,939.85 |
301,842.03 |
298,548.34 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
852.78 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
267,684.88 |
166,139.03 |
411,885.73 |
525,726.37 |
| 负债合计 |
5,389,831.38 |
4,603,175.79 |
6,104,217.24 |
4,521,169.03 |
| 所有者权益 |
| 实收基金 |
1,787,319,437.39 |
2,038,688,944.73 |
2,152,471,628.32 |
2,217,032,596.71 |
| 未分配利润 |
416,422,696.53 |
395,189,212.43 |
270,827,666.97 |
122,734,101.62 |
| 所有者权益合计 |
2,203,742,133.92 |
2,433,878,157.16 |
2,423,299,295.29 |
2,339,766,698.33 |
| 负债及所有者权益总计 |
2,209,131,965.30 |
2,438,481,332.95 |
2,429,403,512.53 |
2,344,287,867.36 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年